What should I bring to my first PIK3CA-Mutant Breast Cancer appointment

Pik_ca_mutant_breast_cancerMay 23, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

What to Bring to Your First PIK3CA-Mutant Breast Cancer Appointment

Great question! Being prepared helps you and your oncology team make the most of your time together. Here's what you should gather:

**Essential [ID removed]

Your pathology report and test results:

  • The report confirming your PIK3CA mutation (this is critical—your doctor will want to review exactly how this was detected and what other biomarkers were tested)
  • ER/PR status (estrogen and progesterone receptor status)
  • HER2 status
  • Any other biomarker testing results (like PD-L1, tumor grade, or additional mutations)
  • Imaging reports (CT, MRI, PET scans with dates)

Previous treatment records (if applicable):

  • Chemotherapy records with drug names and dates
  • Prior hormone therapy or targeted therapy details
  • Radiation therapy summaries
  • Any clinical trial participation records

Lab work:

  • Recent blood work results
  • Tumor marker levels (CA 15-3, CEA) if these were tested

Personal Health Information

  • Complete medication list (including supplements and over-the-counter drugs)
  • Allergy information (especially drug allergies)
  • Family cancer history (write down relatives with cancer, their cancer type, and age at diagnosis)
  • Insurance card and photo ID

Questions to Ask

According to ASCO Guidelines on PIK3CA-mutant breast cancer, your doctor will be considering targeted therapy options. Bring a written list of questions like:

  1. "Based on my PIK3CA mutation, what treatment options are available to me?"

    • The guidelines recommend options like alpelisib, capivasertib, or inavolisib combined with hormone therapy, depending on your specific situation
  2. "What other biomarkers should be tested if they haven't been already?"

    • Your doctor may want to check for ESR1 mutations or AKT1 mutations, which can affect treatment choices
  3. "What are the side effects I should expect, and how are they managed?"

    • For example, alpelisib can cause hyperglycemia (high blood sugar) and diarrhea; capivasertib can cause rash and diarrhea
  4. "What is the treatment plan if my cancer progresses on this therapy?"

  5. "Are there clinical trials I might be eligible for?"

  6. "How often will we monitor my response to treatment?"

Helpful Documents to Bring

  • A notebook or device to take notes during your appointment
  • A trusted person (family member or friend) to help you listen and take notes—appointments can be information-heavy
  • Previous oncology records if you've been treated elsewhere
  • Genetic testing results if you've had germline (inherited) testing done

Why This Matters for PIK3CA Mutations

According to NCCN Guidelines, PIK3CA mutations are "actionable"—meaning they directly guide treatment decisions. Your doctor needs to see:

  • Exactly which PIK3CA mutation you have (there are different types)
  • Whether you have other mutations that might affect treatment
  • Your hormone receptor status (because PIK3CA-targeted therapies are typically combined with hormone therapy for HR-positive breast cancer)

Pro Tips

Request copies of all your test results beforehand if possible—this gives you time to review them
Bring a summary sheet with key dates: diagnosis date, any prior treatments, and current symptoms
Write down your biggest concerns so you don't forget to ask them
Ask about side effect management upfront—this helps you prepare mentally and practically


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: